Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2007
12/04/2007CA2185984C Medicament for the alleviation or treatment of symptom derived from ischemic disease and compound useful therefor
11/2007
11/29/2007WO2007136703A1 Primary amines and derivatives thereof as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto
11/29/2007WO2007136574A2 Medical devices having polymeric regions based on vinyl ether block copolymers
11/29/2007WO2007136572A2 Antidiabetic bicyclic compounds
11/29/2007WO2007136302A2 Active substances, pharmaceutical composition and a method for the production and use thereof
11/29/2007WO2007136300A2 Substituted indoles and a method for the production and use thereof
11/29/2007WO2007136116A2 C-phenyl glycitol compound for the treatment of diabetes
11/29/2007WO2007135969A1 Urea type cinnamide derivative
11/29/2007WO2007135954A1 2-oxetanone derivative and process for production thereof
11/29/2007WO2007135565A2 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
11/29/2007WO2007135527A2 Benzimidazolyl compounds
11/29/2007WO2007135293A2 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
11/29/2007WO2007135131A1 Substituted pyrazinone derivatives for use as a medicine
11/29/2007WO2007134864A1 Indole derivatives and their use as thyroid receptor ligands
11/29/2007WO2007134677A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007WO2007134421A1 2-VINYL INDOLES, PYRIDO AND AZEPINO INDOLE DERIVATIVES, 2-ALKYNYL INDOLES, 2-ALKYNYL BENZO[b]FURANS, THEIR PRECURSORS AND NOVEL PROCESSES FOR THE PREPARATION THEREOF
11/29/2007WO2007110705A3 Macrolide as inhibitors of mhc class ii
11/29/2007WO2007098964A3 Pyrrazole derivatives as sigma receptors antagonists
11/29/2007WO2007090836A3 Piperidine derivatives as cxcr3 receptor antagonists
11/29/2007WO2007090749A3 Benzamide and heteroarene derivatives as cetp inhibitors
11/29/2007WO2007076159A3 Pure darifenacin hydrobromide substantially free of oxidized darifenacin and salts thereof and processes for the preparation thereof
11/29/2007WO2007076158A3 Processes for preparing darifenacin hydrobromide
11/29/2007WO2007076157A3 Processes for preparing darifenacin hydrobromide
11/29/2007WO2007075895A3 Heterocyclic derivatives as modulators of ion channels
11/29/2007WO2007014619A8 Novelimidazolecarboxamide derivatives as fructose-1,6-bisphosphatase inhibitors, and pharmaceutical compositions comprising same
11/29/2007US20070276028 Pesticidal n-phenylpyrazole derivatives
11/29/2007US20070276020 Dicationic Compounds For Activity Against Trichomonas Vaginalis
11/29/2007US20070276012 Process for Preparing Thiazolidinediones
11/29/2007US20070276011 Plasminogen Activator Inhibitor-1 Inhibitor
11/29/2007US20070276010 benzyl-carbamic acid cis-3-[5-(cyclohexanecarbonyl-amino)-1H-pyrazol-3-yl]-cyclobutyl ester; glycogen synthase kinase-3 (GSK-3) inhibitors; inter alia, Alzheimer's Disease, cancer, dementia, depression, diabetes, hair loss, schizophrenia, and stroke
11/29/2007US20070276009 Compositions and Methods for Viral Inhibition
11/29/2007US20070276005 Tri-substitued 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-ol and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-ol analogues, and novel 3,6 disubstituted pyran derivatives
11/29/2007US20070276003 Biphenyl-2-ylcarbamic acid 1-{7-[(R)-2-hydroxy-2-(8-hydroxy-2-oxo-1,2-dihydroquinolin-5-yl)ethylamino]heptyl}piperidin-4-yl ester; beta 2 adrenergic receptor agonist and muscarinic receptor antagonist; bronchodilator agent; pulmonary disorders, chronic obstructive pulmonary disease and asthma
11/29/2007US20070275977 N-oxides of pyridylmethyl -piperazine and -piperidine derivatives
11/29/2007US20070275956 Novel Heterocyclic Compounds
11/29/2007US20070275953 2-Pyridinone Derivatives, Having Hiv Inhibiting Properties
11/29/2007US20070275911 Targeted Drug-Formaldehyde Conjugates and Methods of Making and Using the Same
11/29/2007DE102006024024A1 Substituierte Arylimidazolone und -triazolone sowie ihre Verwendung Substituted Arylimidazolone and -triazolone and their use
11/29/2007CA2652707A1 C-phenyl glycitol compound
11/29/2007CA2652393A1 1,5-diphenylpyrazoles ii as hsp90 inhibitors
11/29/2007CA2652375A1 Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same
11/29/2007CA2651396A1 Urea type cinnamide derivative
11/29/2007CA2651153A1 Antidiabetic bicyclic compounds
11/29/2007CA2651134A1 Indole derivatives and their use as thyroid receptor ligands
11/29/2007CA2649707A1 Substituted pyrazinone derivatives for use as a medicine
11/29/2007CA2649336A1 2-alkoxy-3,4,5-trihydroxy-alkylamide-benzazepines, the preparation and use thereof, and compositions containing the same
11/28/2007EP1860106A1 Tricyclic thrombin receptor antagonists
11/28/2007EP1860104A1 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof
11/28/2007EP1859798A1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
11/28/2007EP1858890A1 Novel antithrombotic substituted pyrrolidinones, the production and use thereof in the form of medicaments
11/28/2007EP1858889A1 Bicyclic nucleosides and nucleotides as therapeutic agents
11/28/2007EP1858888A2 Heteroaryl substituted pyrazinyl-piperazine-piperidines with cxcr3 antagonist activity
11/28/2007EP1858882A1 Pyrimidine derivatives for treatment of hyperproliferative disorders
11/28/2007EP1858869A1 Acylated piperidines as glycine transporter inhibitors
11/28/2007EP1858861A1 Hiv inhibiting 2-(4-cyanophenyl)-6-hydroxylaminopyrimidines
11/28/2007EP1858857A1 Azabicycloalkane derivatives useful as nicotinic acetylcholine receptor agonists
11/28/2007EP1858840A2 Analogs of 4-hydroxyisoleucine and uses thereof
11/28/2007EP1858836A1 Analogues of the azinomycins as anti-tumour agents and as prodrugs
11/28/2007EP1858520A2 Quinazolinone t-type calcium channel antagonists
11/28/2007EP1373257B1 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases
11/28/2007EP1333832B1 Novel uses of combined 5-ht1a agonists and serotonin reuptake inhibitors
11/28/2007EP1315718B1 Bicyclic heterocycles, medicaments containing these compounds, their use, and methods for the production thereof
11/28/2007CN101080401A Substituted biaryl analogues
11/28/2007CN101077873A Novel NEO-clerodane type diterpene compound and application thereof
11/28/2007CN100351252C Novel process for the synthesis of carboxylic acid phenylamide
11/28/2007CN100351249C Quinolinone derivatives as tyrosine kinase inhibitors
11/28/2007CN100351242C Processes and intermediates for preparing anti-cancer compounds
11/28/2007CN100351239C Pyrimidine derivatives and their use as CB2 modulators
11/28/2007CN100351234C Bis-heterocyclic compounds with antitumour and chemosensitising activity
11/28/2007CN100351230C Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester
11/27/2007US7301025 N-(2-(2-(alkyl[carbamoyl, carbonyloxy or ureido]alkyl)pyridinium)-5-(carboxy or sulfo)phenyl-8-((2-(N-alkyl[carbamoyl or ureido]alkyl)pyridinyl) xanthene ligands complexed with a metal or metal-containing moiety; magenta dye with improved heat resistance; hot melts or phase change inks
11/27/2007US7301022 N-(2-(6-7-hydroxy-5,6,7,8-tetrahydronaphthalen-1-ylamino)pyrimidin-4-yl)-5-(trifluoromethyl)phenyl)-1-isopropylpyrrolidine-2-carboxamide hydrochloride; antiinflammatory agents, analgesics, antiarthritic agents, antiulcer agents
11/27/2007US7300950 Pyrazole derivatives, their preparation and their use in pharmaceuticals
11/27/2007US7300946 For use in controlling insects; controlling tobacco budworm
11/27/2007US7300945 For therapy of of certain central nervous system (CNS) diseases, anxiety, depression, a sleep disorder, schizophrenia, or attention deficit-hyperactivity disorder
11/27/2007US7300941 Non-imidazole compounds
11/27/2007US7300937 Derivatives of cyano-aryl (or cyanoheteroaryl)-carbonyl-piperazinyl-pyrimidines, their preparation and application as medication
11/27/2007US7300936 α-(N-sulfonamido)acetamide derivatives as β-amyloid inhibitors
11/27/2007CA2358998C Substituted bicyclic derivatives useful as anticancer agents
11/27/2007CA2290557C Use of 4-substituted tetrahydropyridines for making medicines acting on tgf-.beta.1
11/22/2007WO2007133597A1 Crystalline form of atorvastatin calcium stable after storage
11/22/2007WO2007133108A1 Pharmaceutical composition, method for the production and the use thereof
11/22/2007WO2007132990A1 Process for the preparation of chiral glycidylphthalimide in highly optical purity
11/22/2007WO2007132948A1 Cinnamoyl compound and use thereof
11/22/2007WO2007132886A1 Organic electroluminescent device material, organic electroluminescent device, display and illuminating device
11/22/2007WO2007132010A1 2, 4 -diamino pyrimidines as cell cycle kinase inhibitors
11/22/2007WO2007105989A3 1-oxo-3-(1h-indole)-3-il-1,2,3,4-tetrahydroisoxynolines, methods for the production thereof, combinatoric library and focused library
11/22/2007WO2007095495A3 Benzodiazepine gcnf modulators for stem cell modulation
11/22/2007WO2007075783A3 Substituted isoquinoline-1,3(2h,4h)-diones, 1-thioxo-1,4-dihydro-2h-isoquinoline-3-ones and 1,4-dihydro-3(2h)-isoquinolones and use thereof as kinase inhibitor
11/22/2007WO2007062314A3 Heterocyclic cetp inhibitors
11/22/2007WO2006135839A3 Piperazine-piperidine antagonists and agonists of the 5-ht1a receptor
11/22/2007WO2006100208A9 1-benzylindole-2-carboxamide derivatives
11/22/2007WO2005046589A3 Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties
11/22/2007US20070270478 e.g. 3-[4-(3,5-bis-trifluoromethyl-pyrazol-1-yl)-phenyl]-2-(2,3-difluoro-phenyl)-acrylonitrile; immunosuppressant; bioavailability; side effect reduction; interleukin-2 inhibitor
11/22/2007US20070270474 Pyrazole compounds for treatment of neurodegenerative disorders
11/22/2007US20070270466 Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-HT1F agonists
11/22/2007US20070270464 Prodrugs of curcumin analogs
11/22/2007US20070270451 Methods of preparing pimecrolimus
11/22/2007US20070270444 (5-Methyl-2H-pyrazol-3-yl)-(2-phenylsulfanyl-quinazolin-4-yl)-amine; Anticancer agents; antidiabetic agents; Alzheimer's disease; inhibitors of Aurora-2 and GSK-3
11/22/2007US20070270439 nor-seco himbacine derivatives; thrombosis, anticoagulants, anticancer agents; antiinflammatory agents; anticholesterol agents; cardiovascular disorders; antiarrhythmia agents; antiischemic agents; strokes; antiarthritic agents
1 ... 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 ... 694